openPR Logo
Press release

Breast Cancer Liquid Biopsy Market Comprehensive Study 2018: MDxHealth, QIAGEN, Guardant Health, Janssen Inc., Roche, Menarini Silicon Biosystems, Thermo Fisher Scientific, Biocept, Inc, Trovagene, Bio-Rad Laboratories, RainDance Technologies

10-11-2018 04:09 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

/ PR Agency: Data Bridge Market Research
Global Breast Cancer Liquid Biopsy Market

Global Breast Cancer Liquid Biopsy Market

Global Breast Cancer Liquid Biopsy market report is a window to the industry which explains what market definition, classifications, applications, engagements and market trends are. The Breast Cancer Liquid Biopsy Industry report provides an in-depth overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin. The global Breast Cancer Liquid Biopsy market report also contains the drivers and restrains for the market that are derived from SWOT analysis, and also shows what all the recent developments, product launches, joint ventures, merges and accusations by the several key players and brands that are driving the market are by systemic company profiles.

Global Breast Cancer Liquid Biopsy Market is expected to reach USD 761.73 million by 2025, from USD 145.4 million in 2017 growing at a CAGR of 23.0% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Sample PDF Available | Reuest At https://databridgemarketresearch.com/request-a-sample/?dbmr=global-breast-cancer-liquid-biopsy-market

In August 2017, Cynvenio Biosystems, Inc. (Westlake Village, CA), launched its new ClearID HER2 Expression Test. This new test allows doctors to perform real-time monitoring and gets analysis of HER2 levels in their patients without tissue biopsy.

Competitors/Players: Global Breast Cancer Liquid Biopsy Market

• MDxHealth,
• QIAGEN,
• GUARDANT HEALTH, INC,
• Janssen Global Services, LLC,
• F. Hoffmann-La Roche Ltd,
• Menarini Silicon Biosystems.,
• Thermo Fisher Scientific Inc,
• Biocept, Inc,
• Trovagene,
• Bio-Rad Laboratories, Inc.,
• RainDance Technologies, Inc.,
• Myriad Genetics, Inc,
• Fluxion Biosciences, Inc.,
• Isogen Life Science B.V.,
• Cynvenio Biosystems, Inc.
• Guardant Health, Inc.,
• Biodesix, Inc,
• Genomic Health,
• FOUNDATION MEDICINE, INC,
• Sysmex Corporation,
• Exosome Diagnostics,
• NeoGenomics Laboratories,
• among others.

Competitive Analysis:

The Global Breast Cancer Liquid Biopsy Market is highly fragmented and the major players have used various strategies such product launches, technology developments, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Continuous Manufacturing market for global, Europe, North America, Asia Pacific and South America.

Table of Contents:

1 Introduction
2 Research Methodologies
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Compliance in Breast Cancer Liquid Biopsy Market
8 Breast Cancer Liquid Biopsy Market, By Service
9 Breast Cancer Liquid Biopsy Market, By Deployment Type
10 Breast Cancer Liquid Biopsy Market, By Organization Size
11 Breast Cancer Liquid Biopsy Market Analyses, By Vertical
12 Geographic Analyses
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa
13 Competitive Landscapes
14 Detailed Company Profiles
15 Related Reports

Detailed TOC Available|Request At : https://databridgemarketresearch.com/toc/?dbmr=global-breast-cancer-liquid-biopsy-market

Drivers and Restraints:

• Rising applications of liquid biopsy.

• Rising geriatric population along with cancer incidences.

• Increasing focuses on R&D in medical field for cancers.

• Clinical utility challenges towards liquid biopsy.

Key Developments in the Market:

• In August 2017, Cynvenio Biosystems, Inc. (WESTLAKE VILLAGE) launched its second generation PD-L1 expression test. This new blood test offers improved analytic performance as compare to first generation PD-L1 test and has high sensitivity, specific profiling and monitoring of PD-L1 expression on lung cancer cells recovered from a simple blood draw.

• In May 2017, Cynvenio Biosystems Inc. (Westlake Village, Calif), released ClearID Total Insight Breast Cancer which is a liquid biopsy monitoring service for patients to treat cancer related problems.

Primary Respondents

• Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

• Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others

Core Objectives of Breast Cancer Liquid Biopsy market research

• To analyze global Breast Cancer Liquid Biopsy status, future forecast, growth opportunity, key market and key players.

• To present the Breast Cancer Liquid Biopsy development in United States, Europe and China.

• To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by product type, market and key regions.

Feel Free To Ask More Insights | Request Analyst Call at https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-breast-cancer-liquid-biopsy-market

Segmentation: Global Breast Cancer Liquid Biopsy Market

The global breast cancer liquid biopsy market is segmented based on

• product,
• circulating biomarkers,
• end user and
• geographical segments

Based on product type, the market is segmented into

• consumables
• kits

On the basis of circulating biomarkers, the market is segmented into

• Extracellular Vesicles (EVs),
• Cell-free DNA (cfDNA),
• ctRNA,
• Circulating Tumor Cells (CTCs)
• cfRNA

On the basis of end users, the market is segmented into

• laboratories,
• hospitals,
• physician laboratories,
• public health laboratories,
• research institutes,
• small molecular laboratories
• pathology laboratories

Based on geography, the market report covers data points for 28 countries across multiple geographies namely

• North America & South America,
• Europe,
• Asia-Pacific and,
• Middle East & Africa.

What Reports Provides.

• Full in-depth analysis of the parent Breast Cancer Liquid Biopsy market

• Segmentation details of the market

• Former, on-going, and projected market analysis in terms of volume and value

• Assessment of niche industry developments

• Important changes in Breast Cancer Liquid Biopsy Industry dynamics

• Market share analysis

• Key strategies of major players In

• Emerging segments and regional markets

• Testimonials to companies in order to fortify their foothold in the Breast Cancer Liquid Biopsy market.

Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want.

Inquire For Customization With Discount | https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-breast-cancer-liquid-biopsy-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavorsto provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Breast Cancer Liquid Biopsy Market Comprehensive Study 2018: MDxHealth, QIAGEN, Guardant Health, Janssen Inc., Roche, Menarini Silicon Biosystems, Thermo Fisher Scientific, Biocept, Inc, Trovagene, Bio-Rad Laboratories, RainDance Technologies here

News-ID: 1297591 • Views:

More Releases from Data Bridge Market Research

Preparative and Process Chromatography Market CAGR of 8.8% by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Preparative and Process Chromatography Market CAGR of 8.8% by 2029, Size, Share, …
"Preparative and Process Chromatography Market research report has been prepared with the systematic gathering and evaluation of market information for industry which is presented in a form that explains various facts and figures to the business. Report saves valuable time as well as adds credibility to the work that is performed to grow business. This quality report has been planned with full commitment and transparency in research and analysis.
Neonatal Seizures Drugs Market CAGR of 3.40% by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Neonatal Seizures Drugs Market CAGR of 3.40% by 2029, Size, Share, Trends, Deman …
"Global Sodium Lactate Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. The document also explains key elements such as revenue, business distribution, market share, shipment, gross profit, and more. All these elements help the readers to understand more information about industry competitors. Being the most suitable example of the above attributes, the
Cold Chain Monitoring Components Market CAGR of 15.3% by 2028, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Cold Chain Monitoring Components Market CAGR of 15.3% by 2028, Size, Share, Tren …
Data Bridge Market research has recently released expansive research titled Global Cold Chain Monitoring Components Market guarantees you will remain better informed than your competition.The report is formulated based on the market type, organization size, availability on-premises, the end-users' organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Businesses can accomplish knowledge about complete background analysis of the
Sodium Hypophosphite: Unveiling the Power of this Essential Chemical Compound
Sodium Hypophosphite: Unveiling the Power of this Essential Chemical Compound
The rise in demand for water treatment in industrial applications across the globe acts as one of the major factors driving the growth of sodium hypophosphite market. The rise in usage of sodium hypophosphite in the electroplating application as reducing agents, and increase in electroplating of metal surface assist in enhancing properties such as abrasion resistance, hardness, corrosion resistance, and strength among others accelerate the market growth. The increase in

All 5 Releases


More Releases for Breast

Breast Ultrasound Market Research Report and Forecast to 2028 - Conventional Bre …
A breast ultrasound is an imaging method chiefly utilized to screen for tumours and other breast abnormalities. The ultrasound use high-frequency sound waves for the production of detailed images of the inside of the breasts. The global Breast Ultrasound Market is expected to grow at a significant CAGR of 14.6% by 2028. The updated report on the Breast Ultrasound market gives a precise analysis of the value chain assessment for the review
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues. Download Free PDF Brochure on Brest Imaging Market Report Now
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to
Automated Breast Ultrasound Systems – The Future of Breast Screening
Breast cancer is the most commonly diagnosed type of cancer and the second leading cause of death among women, as evident from stats revealed by the National Breast Cancer Foundation. Growing awareness of breast cancer has increased number of women undergoing breast screening and in turn would propel demand for automated breast ultrasound systems (ABUS) in hospitals and diagnostic centers. ABUS enables physicians to screen women, especially with denser breasts
Soaring Instances of Breast Cancer to Propel Breast Imaging Market
"The Report Breast Imaging Market (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging and Others [Breast Thermography & Bioelectric Imaging]) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" An intelligence report on the global breast imaging market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Breast Imaging
What Is A Combined Breast Augmentation With Breast Lift?
Combined Breast Augmentation And Lift: How Is It Performed? Surrounding the areola one incisions is made to remove the excess skin and another vertically incisions is made to the base of breasts starting from low part of the areola. Sometimes the scar is referred to as the “Lollipop scar”. Implants are placed through the incisions made and positioned carefully by the surgeon under the pectoral chest muscle, where the implants can